Dextromethorphan is not a dangerous drug under Chap. 11:25: the First Schedule names it in order to except it. Item 11, «Morphinans, their preparations, derivatives and salts, as for example:», lists seven morphinans, among them Levomethorphan and Racemethorphan, and then prints «not including:» before «(8) Dextromethorphan», «(9) Dextrorphan» and «(10) Levallorphan». The clause at the end of that Schedule adds «The isomers unless specifically excepted, of the drugs in this Schedule», and dextromethorphan is specifically excepted, so the clause does not bring it back. The next two clauses, «The esters and ethers, unless appearing in another Schedule, of the drugs» in this Schedule and «The salts of the drugs listed in this Schedule, including the salts of esters,» ethers and isomers, reach esters, ethers and salts of the drugs the Schedule lists. Unlike the isomers clause, the esters and ethers clause carries no «unless specifically excepted» words, but the printed list closes that route without them. Dextromethorphan is understood to be the methyl ether of dextrorphan, a chemical fact brought from outside the text, and dextrorphan is printed in the same excepted list as «(9) Dextrorphan», so it is not one of «the drugs in this Schedule» and there is no listed parent for the ether route to work from; dextromethorphan itself is printed there as «(8) Dextromethorphan», so it is not a listed drug whose salts the salts clause could reach, including the hydrobromide in which it is understood to be usually sold, also a fact from outside the text. The racemic methyl ether is printed as its own entry, «(6) Racemethorphan», and the dextro ether is the one item 11 excepts by name; that pairing rests on the same outside chemistry. Legal Notice No. 343 of 2019 amended only item 4 of the First Schedule, and dextromethorphan is not listed in any Second Schedule table, as those tables stand after Legal Notice No. 293 of 2026. As at 3 October 2026, the date the instruments were read, it therefore falls outside the section 3 definition of dangerous drugs, and the section 5 possession and trafficking offences do not reach it through a listing.
Dangerous Drugs Act, Chap. 11:25, consolidation updated to 31 December 2016, revision 105641, https://laws.gov.tt/ttdll-web/revision/download/105641?type=act: First Schedule item 11 on page 41, the isomers clause on page 42, item 1(2) on page 37, and sections 3, 5, 8, 57 and 61. Legal Notice No. 343 of 2019, Dangerous Drugs (Amendment of the First Schedule) Order, 2019, https://laws.gov.tt/ttdll-web/revision/download/108636?type=amendment, read for its First Schedule changes, which are to item 4 only. Second Schedule Orders read for the absence: Legal Notices No. 345 of 2019 (https://laws.gov.tt/ttdll-web/revision/download/108640?type=amendment), 166 of 2023 (https://laws.gov.tt/ttdll-web/revision/download/117076?type=amendment), 131 of 2024 (https://laws.gov.tt/ttdll-web/revision/download/119398?type=amendment) and 293 of 2026 (https://laws.gov.tt/ttdll-web/revision/download/124452?type=amendment). Act No. 24 of 2019, https://laws.gov.tt/ttdll-web/revision/download/108733?type=amendment, in operation from 23 December 2019 by Legal Notice No. 397 of 2019, https://laws.gov.tt/ttdll-web/revision/download/108756?type=amendment. Read 3 October 2026. Section 61 of the consolidation was read for the penalty sentence. Legal Notice No. 293 of 2026 prints no commencement date of its own · nothing in this cell turns on the row it adds. · Verified October 3, 2026
Ketamine is a dangerous drug under Chap. 11:25 from 3 February 2020. Legal Notice No. 345 of 2019, by clause 3(c), which its clause 2(2) brought into operation on that date, inserted a third table in the Second Schedule headed «OTHER PSYCHOTROPIC SUBSTANCES:», and its only row prints the international non-proprietary name «KETAMINE», the other names «KETALAR», «KETASET» and «KTMIN», and the chemical name «2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one». The same clause closes the Schedule with lines extending it to «The salts of the substances listed in this Schedule» and to their stereoisomers, which reaches the hydrochloride. Ketamine was absent from the consolidation updated to 31 December 2016.
Legal Notice No. 345 of 2019, clauses 2(2) and 3(c), page 1083, https://laws.gov.tt/ttdll-web/revision/download/108640?type=amendment, read with the Dangerous Drugs Act, Chap. 11:25, consolidation updated to 31 December 2016, sections 3, 5, 8, 11, 20 and 29A, https://laws.gov.tt/ttdll-web/revision/download/105641?type=act, and with Act No. 24 of 2019, sections 6(a), 6(f), 6(k)(iii) and 9, https://laws.gov.tt/ttdll-web/revision/download/108733?type=amendment, in operation 23 December 2019 (Legal Notice No. 397 of 2019, https://laws.gov.tt/ttdll-web/revision/download/108756?type=amendment). The 2023, 2024 and 2026 Second Schedule Orders, Legal Notices No. 166 of 2023 (https://laws.gov.tt/ttdll-web/revision/download/117076?type=amendment), 131 of 2024 (https://laws.gov.tt/ttdll-web/revision/download/119398?type=amendment) and 293 of 2026 (https://laws.gov.tt/ttdll-web/revision/download/124452?type=amendment), amend only the Schedule II table. Stated as the Schedules stand after Legal Notice No. 293 of 2026 · read 3 October 2026. Section 61 of the consolidation was read for the penalty sentences. Also read: Legal Notice No. 395 of 2019, Regulations under section 57, https://laws.gov.tt/ttdll-web/revision/download/108754?type=amendment. Legal Notice No. 293 of 2026 prints no commencement date of its own · nothing in this cell turns on the row it adds. · Verified October 3, 2026
Methoxetamine is in the Second Schedule to the Dangerous Drugs Act, Chap. 11:25, in the table «PSYCHOTROPIC SUBSTANCES LISTED IN SCHEDULE II OF THE» Convention on Psychotropic Substances, 1971, which clause 3(b) of LN 345/2019 inserted with effect from 18 November 2019. Its row prints «METHOXETAMINE» in the INN column, «MXE» as the other name and, as the chemical name, «2-(Ethylamino)-2-(3-» «methoxyphenyl)cyclohexanone», so the substance is named directly and no inference from a related compound is needed. From 3 February 2020 the closing lines clause 3(c) of the same Order added extend the Schedule to «The salts of the substances listed in this Schedule whenever the» existence of such salts is possible, and to stereoisomers within the specific chemical designation. Ketamine, the only row of the separate «OTHER PSYCHOTROPIC SUBSTANCES:» table, and «PHENCYCLIDINE», another row of the Schedule II table, are different compounds and are not relied on. Position as at 3 October 2026.
LN 345/2019, the Dangerous Drugs (Amendment of the Second Schedule) Order, 2019, clauses 2, 3(b) and 3(c), https://laws.gov.tt/ttdll-web/revision/download/108640?type=amendment · read into the Dangerous Drugs Act, Chap. 11:25, consolidation «UPDATED TO 31ST DECEMBER 2016», which the Ministry prints as an «UNOFFICIAL VERSION», revision 105641, https://laws.gov.tt/ttdll-web/revision/download/105641?type=act, Second Schedule and sections 5, 19, 22 and 61 · and the Dangerous Drugs (Amendment) Act, 2019, Act No. 24 of 2019, https://laws.gov.tt/ttdll-web/revision/download/108733?type=amendment, brought into operation on 23 December 2019 by LN 397/2019, https://laws.gov.tt/ttdll-web/revision/download/108756?type=amendment, section 6 of that Act. Read on 3 October 2026. · Verified October 3, 2026
PCP is a dangerous drug under Chap. 11:25 from 18 November 2019, when Legal Notice No. 345 of 2019 came into operation. Its clause 3(b) inserted the Second Schedule table headed «PSYCHOTROPIC SUBSTANCES LISTED IN SCHEDULE II OF THE CONVENTION ON PSYCHOTROPIC SUBSTANCES, 1971, VIZ:», which prints the international non-proprietary name «PHENCYCLIDINE», the other name «PCP» and the chemical name «1-(1-Phenylcyclohexyl)piperidine». Before that Order the consolidation updated to 31 December 2016 carried three of its analogues in the Schedule I table, «ETICYCLIDINE» («PCE»), «ROLICYCLIDINE» («PHP, PCPY») and «TENOCYCLIDINE» («TCP»), but not phencyclidine itself.
Second Schedule, Schedule II table, «PHENCYCLIDINE», inserted by Legal Notice No. 345 of 2019, clause 3(b), page 1082, https://laws.gov.tt/ttdll-web/revision/download/108640?type=amendment · earlier Schedule I rows «ETICYCLIDINE», «ROLICYCLIDINE» and «TENOCYCLIDINE» in the Dangerous Drugs Act, Chap. 11:25, as updated to 31 December 2016, page 43, https://laws.gov.tt/ttdll-web/revision/download/105641?type=act, with sections 5, 17 and 56A. Act No. 24 of 2019, sections 6(a), 6(f), 6(g) and 6(k), https://laws.gov.tt/ttdll-web/revision/download/108733?type=amendment, in force 23 December 2019 per Legal Notice No. 397 of 2019, https://laws.gov.tt/ttdll-web/revision/download/108756?type=amendment. Also read: Legal Notices No. 166 of 2023, https://laws.gov.tt/ttdll-web/revision/download/117076?type=amendment, No. 131 of 2024, https://laws.gov.tt/ttdll-web/revision/download/119398?type=amendment, and No. 293 of 2026, https://laws.gov.tt/ttdll-web/revision/download/124452?type=amendment. Read 3 October 2026 · as the Schedules stand after Legal Notice No. 293 of 2026. Section 61 of the consolidation was read for the penalty sentences. Also read: Legal Notice No. 395 of 2019, Regulations under section 57, https://laws.gov.tt/ttdll-web/revision/download/108754?type=amendment. Legal Notice No. 293 of 2026 prints no commencement date of its own · nothing in this cell turns on the row it adds. · Verified October 3, 2026